Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RALPH BOCCIA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1881663284
CMS profile
175674
Location
BETHESDA, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$415,808.04

493 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Ownership and Investment Interests

CMS also publishes Ownership and Investment Interests as a separate dataset. This site does not currently mirror it, and no ownership figure is shown on this page. This provider appears in that dataset.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
BeiGene USA, Inc. $56,519.73 40
AbbVie Inc. $53,767.99 39
Genmab U.S., Inc. $40,354.02 39
GENZYME CORPORATION $37,704.52 27
Pharmacosmos Therapeutics Inc. $35,372.41 22
SOBI, INC $22,985.60 9
Janssen Biotech, Inc. $22,749.37 29
Amgen Inc. $19,032.53 16
Regeneron Healthcare Solutions, Inc. $17,770.57 20
G1 Therapeutics, Inc. $17,446.16 12
AstraZeneca Pharmaceuticals LP $16,289.17 19
Daiichi Sankyo Inc. $14,396.01 19
Rigel Pharmaceuticals, Inc. $13,357.65 17
Karyopharm Therapeutics Inc. $12,765.88 16
Mirati Therapeutics, Inc. $9,980.54 11
Ipsen Biopharmaceuticals, Inc $9,683.38 5
Lilly USA, LLC $5,100.68 5
CTI BioPharma Corp. $4,800.00 1
Pharmacyclics LLC, An AbbVie Company $913.89 7
Janssen Global Services, LLC $735.48 1
Novartis Pharmaceuticals Corporation $554.54 19
Incyte Corporation $278.50 12
Celgene Corporation $276.18 8
PharmaEssentia USA Corporation $229.12 5
Coherus Biosciences Inc. $207.70 4
Gilead Sciences, Inc. $190.06 6
PFIZER INC. $186.75 7
Seagen Inc. $179.09 8
Myriad Genetic Laboratories, Inc. $168.49 4
Merck Sharp & Dohme LLC $162.37 7
MorphoSys, US Inc. $151.09 3
Genentech, Inc. $148.63 1
Spectrum Pharmaceuticals Inc. $133.13 3
E.R. Squibb & Sons, L.L.C. $122.02 7
Blueprint Medicines Corporation $92.47 1
Eisai Inc. $85.69 4
EAGLE PHARMACEUTICALS, INC. $79.44 1
Exelixis Inc. $67.01 3
Astellas Pharma US Inc $65.20 3
AVEO Pharmaceuticals, Inc. $63.86 2
Bayer Healthcare Pharmaceuticals Inc. $55.57 2
Genentech USA, Inc. $47.75 2
Takeda Pharmaceuticals U.S.A., Inc. $47.25 2
Kite Pharma, Inc. $45.73 2
Acrotech Biopharma Inc. $44.59 3
Janssen Pharmaceuticals, Inc $39.93 2
Alexion Pharmaceuticals, Inc. $39.81 2
ARRAY BIOPHARMA INC $39.53 3
GlaxoSmithKline, LLC. $35.49 2
Puma Biotechnology, Inc. $32.58 2
Stemline Therapeutics Inc. $31.51 1
Sumitomo Pharma America, Inc. $28.61 1
EMD Serono, Inc. $25.72 1
TAIHO ONCOLOGY, INC. $25.49 1
ADC Therapeutics America, Inc. $22.39 1
SERVIER PHARMACEUTICALS LLC $20.50 1
Apellis Pharmaceuticals, Inc. $20.27 1
Alnylam Pharmaceuticals Inc. $19.32 1
Boehringer Ingelheim Pharmaceuticals, Inc. $19.08 1

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

493 matching records · $415,808.04 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 493 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 493.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Incyte Corporation $22.4811/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261044383603 CMS
Karyopharm Therapeutics Inc. $126.3611/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056907327 CMS
AstraZeneca Pharmaceuticals LP $2,740.0011/22/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261012019107 CMS
Exelixis Inc. $31.9011/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261044624865 CMS
Incyte Corporation $17.1811/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261044383585 CMS
Genmab U.S., Inc. $8,925.0011/21/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051347485 CMS
AbbVie Inc. $2,325.0011/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026996274673 CMS
AbbVie Inc. $172.5011/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026996274667 CMS
AbbVie Inc. $35.0011/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026996274669 CMS
AbbVie Inc. $275.8011/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026996274671 CMS
AbbVie Inc. $5,425.0011/17/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026996274665 CMS
BeiGene USA, Inc. $150.0011/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051187521 CMS
BeiGene USA, Inc. $360.0011/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051187523 CMS
BeiGene USA, Inc. $4,500.0011/16/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051187525 CMS
Genmab U.S., Inc. $5,425.0011/16/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051347481 CMS
G1 Therapeutics, Inc. $5,500.0011/15/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059916653 CMS
Rigel Pharmaceuticals, Inc. $21.9011/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261033435273 CMS
Seagen Inc. $26.3011/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995721405 CMS
Spectrum Pharmaceuticals Inc. $96.2811/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059886067 CMS
Pharmacyclics LLC, An AbbVie Company $26.8811/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026998282365 CMS
Pharmacyclics LLC, An AbbVie Company $2.5311/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026998282367 CMS
SOBI, INC $3,700.0011/09/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261038125893 CMS
Pharmacosmos Therapeutics Inc. $13.3211/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261046243065 CMS
AbbVie Inc. $14.5811/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026996274663 CMS
Pharmacosmos Therapeutics Inc. $157.0011/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261046243057 CMS
AstraZeneca Pharmaceuticals LP $1,350.0011/06/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014807601 CMS
Daiichi Sankyo Inc. $172.5011/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006583009 CMS
Daiichi Sankyo Inc. $273.9011/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006605223 CMS
Daiichi Sankyo Inc. $5,500.0011/06/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006605281 CMS
Daiichi Sankyo Inc. $1,350.0011/06/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006605499 CMS
Genmab U.S., Inc. $303.9711/04/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051347463 CMS
Genmab U.S., Inc. $372.8011/04/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051347465 CMS
Genmab U.S., Inc. $14.9911/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051347469 CMS
Genmab U.S., Inc. $49.9911/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051347471 CMS
Genmab U.S., Inc. $14.9911/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051347473 CMS
Genmab U.S., Inc. $94.2111/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051347483 CMS
Genmab U.S., Inc. $16.9711/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051347487 CMS
SOBI, INC $3,700.0011/03/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261038125815 CMS
Daiichi Sankyo Inc. $443.4311/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006605309 CMS
Mirati Therapeutics, Inc. $1,600.0011/02/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261057986997 CMS
Novartis Pharmaceuticals Corporation $25.0911/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026991759009 CMS
Daiichi Sankyo Inc. $375.5311/01/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006605337 CMS
Janssen Biotech, Inc. $337.5011/01/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988697983 CMS
Novartis Pharmaceuticals Corporation $27.9511/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026991758997 CMS
PFIZER INC. $23.7010/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050067515 CMS
AstraZeneca Pharmaceuticals LP $23.0410/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015641747 CMS
Daiichi Sankyo Inc. $4,100.0010/27/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006601065 CMS
Janssen Pharmaceuticals, Inc $19.4710/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988611339 CMS
MorphoSys, US Inc. $106.5110/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261060329291 CMS
Novartis Pharmaceuticals Corporation $23.8610/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026991759001 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $707,458.24 649
PY2020 $452,016.98 405
PY2021 $393,668.10 454
PY2022 $493,041.79 506
PY2023 $415,808.04 493
PY2024 $433,660.62 450
PY2025 $244,074.29 326

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
RALPH BOCCIA, NPI 1881663284. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1881663284.
APA 7
IndustryPayments. (2026). RALPH BOCCIA, NPI 1881663284 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1881663284
Bluebook
RALPH BOCCIA, NPI 1881663284, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1881663284.

Source: Centers for Medicare & Medicaid Services, Open Payments.